Guest post: PhRMA talks racial and health equity with Stephanie Dyson, Head of Office at Biogen

Our industry has committed itself to making our workplaces trusting places to have complex, and sometimes difficult, conversations about diversity and inclusion.
Read More
New report highlights biopharmaceutical industry’s commitment to D&I

Today, PhRMA released a new report prepared by TEConomy Partners, LLC that provides insights into the efforts of biopharmaceutical companies to advance diversity & inclusion (D&I) in the...
Read More
Strengthening a culture dedicated to patients and equity: A conversation with Percival Barretto-Ko, President of Astellas US

This year our industry has been working around the clock to combat the COVID-19 virus, including developing effective therapeutics to treat COVID-19 and vaccines to prevent future infections....
Read More
Sharing rebates can improve access to medicines and increase health equity

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
PhRMA will continue to advocate for equity within our industry

When I first started at PhRMA two and a half years ago, our organization was just starting to talk about how we could increase and activate our commitment to diversity & inclusion (D&I). As senior...
Read More
Three ways the pharmaceutical industry can positively impact health equity

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
Systemic racism is as real as any disease, and our industry is not immune

This month, PhRMA published our commitment to racial equity and inclusion in the New York Times as well as in the Informer and the AfroAmerican, DC-based, Black-owned newspapers. This public...
Read More